Keyphrases
Transforming Growth Factor-β
100%
Metastatic Breast Cancer
71%
Renal Cell Carcinoma
68%
Circulating Tumor DNA (ctDNA)
51%
Prostate Cancer
50%
Tumor
48%
Circulating Tumor Cells
40%
CD8+ T Cells
29%
Complementary DNA (cDNA)
27%
Human Renal Cell Carcinoma
22%
Adoptive Transfer
20%
Tumor Cells
19%
Renca
18%
Differentially Expressed Genes
17%
Novel Genes
16%
Activin Type II Receptor
16%
Suppression Subtractive Hybridization
15%
Subtractive Library
15%
Next-generation Sequencing
14%
Estrogen Receptor 1 (ESR1)
14%
Circulating Tumor Cell Clusters
14%
HER2-positive
13%
Cell Tumor
13%
Normal Kidney
13%
In Cancer
13%
Cancer Progression
13%
Dendritic Cells
12%
Growth Factor Signaling
12%
Chemotherapy
12%
Genetic Modification
12%
T Cells
12%
Induced Expression
12%
Transforming Growth Factor-β Signaling
11%
Hepatocellular Carcinoma
11%
Functional Studies
11%
Prostate-specific Antigen
11%
Expressed Genes
11%
Dominant Negative
11%
TGF-β Receptor
10%
Apoptosis
10%
Liquid Biopsy
10%
Cancer Development
10%
CD4+
10%
CD25
10%
Cancer Cells
9%
Tumor Growth
9%
5-aza-2′-deoxycytidine
9%
Breast Cancer
8%
Mouse Prostate
8%
PIK3CA
8%
Medicine and Dentistry
Metastatic Breast Cancer
64%
Cancer Growth Factor
47%
Prostate Cancer
44%
Neoplasm
43%
Circulating Tumor DNA
41%
Circulating Tumor Cell
34%
Clear Cell Renal Cell Carcinoma
31%
Transforming Growth Factor Beta
23%
Malignant Neoplasm
20%
Metastatic Carcinoma
20%
Cytotoxic T-Cell
19%
Receptor
18%
Adoptive Transfer
17%
Prostate Specific Membrane Antigen
17%
Diseases
15%
Cancer Cell
13%
Tumor Progression
12%
Tumor Cell
11%
In Vitro
10%
Liquid Biopsy
10%
Breast Cancer
9%
Lung Metastasis
8%
Programmed Cell Death
8%
Stromal Cell
8%
Carcinogenesis
8%
Epithelial Cell
7%
Chemotherapy
7%
DNA Methylation
7%
Immunotherapy
7%
Hormone Receptor
6%
Dendritic Cell
6%
Clinical Study
6%
Infection
6%
Prostate Cancer Diagnosis
5%
B-Cell Lymphoma
5%
Left Atrium
5%
Premenopause
5%
Positron Emission Tomography
5%
Prothrombin
5%
T Cell
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Lung Adenocarcinoma
5%
Drug Resistance
5%
Vimentin
5%
Kidney Carcinoma
5%
Positron Emission Tomography-Computed Tomography
5%
Clinical Significance
5%
Prostatectomy
5%
Progression Free Survival
5%
Gene Mutation
5%
Biochemistry, Genetics and Molecular Biology
Cancer Growth Factor
47%
Circulating Tumor DNA
38%
Suppression Subtractive Hybridization
28%
Protein Sequencing
24%
Northern Blotting
23%
Cancer Cell
22%
Tumor Suppressor Gene
20%
Oncogene
20%
Genomics
20%
Rapid Amplification of cDNA Ends
19%
T Cell
17%
CD8
17%
Transforming Growth Factor Beta
17%
Tumor Progression
14%
Dendritic Cell
12%
Methylation
11%
Next Generation Sequencing
9%
Stromal Cell
9%
Gene Frequency
9%
Restriction Enzyme
8%
Promoter Region
8%
Carcinogenesis
8%
Antigen Specificity
7%
Hormone Receptor
7%
Glycoprotein
7%
Dynamics
7%
Fibrinogen
7%
Tumor Antigen
7%
DNA Methyltransferase
6%
Autoinduction
6%
LNCaP
6%
Decitabine
6%
Plasmid
6%
Enzyme
5%
Clusterin
5%
B Cell
5%
Drive
5%
Plasmid Vector
5%
Antisense
5%
RNA
5%
CD68
5%
Oligonucleotide
5%
DNA Methylation
5%
GAS6
5%
Mediator
5%
Western Blotting
5%
Fibroblast
5%
CX3CR1
5%
Cell Mutant
5%
Progression Free Survival
5%